Mild alpha thalassaemia diseases (Q39519): Difference between revisions

From determinar.ia.br - Determine suas informações
Changed label, description and/or aliases in pt-br, en
Changed an Item
 
(6 intermediate revisions by the same user not shown)
Property / Canonical URI
 
Property / Canonical URI: https://id.who.int/icd/entity/1932608766 / rank
 
Normal rank
Property / CURIE
 
CID11:3A50.00
Property / CURIE: CID11:3A50.00 / rank
 
Normal rank
Property / Canary Token
 
dki-india-3A50.00
Property / Canary Token: dki-india-3A50.00 / rank
 
Normal rank
Property / Verification Status
 
Concluído
Property / Verification Status: Concluído / rank
 
Normal rank
Property / Knowledge Architect
 
Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank
 
Normal rank
Property / Collection date
 
13 August 2026
Timestamp+2026-08-13T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / Collection date: 13 August 2026 / rank
 
Normal rank
Property / Linked ICD 10
 
Property / Linked ICD 10: D56.3 / rank
 
Normal rank

Latest revision as of 04:58, 13 August 2026

A disease caused by genetically inherited factors affecting the alpha chain of the haemoglobin molecule. This disease is characterised by structural abnormalities of the haemoglobin molecule. This disease may present with mild anaemia: pallor, fatigue, shortness of breath. Confirmation is by identification of changes to the alpha chain by genetic testing.
Language Label Description Also known as
default for all languages
3A50.00
    English
    Mild alpha thalassaemia diseases
    A disease caused by genetically inherited factors affecting the alpha chain of the haemoglobin molecule. This disease is characterised by structural abnormalities of the haemoglobin molecule. This disease may present with mild anaemia: pallor, fatigue, shortness of breath. Confirmation is by identification of changes to the alpha chain by genetic testing.

      Statements

      CID11:3A50.00
      0 references
      dki-india-3A50.00
      0 references
      Concluído
      0 references
      13 August 2026
      0 references
      0 references